Abstract:Background: The heart grows in response to pathological and physiological stimuli. The former often precedes cardiomyocyte loss and heart failure; the latter paradoxically protects the heart and enhances cardiomyogenesis. The mechanisms underlying these differences remain incompletely understood. Although long noncoding RNAs (lncRNAs) are important in cardiac development and disease, less is known about their roles in physiological hypertrophy or cardiomyogenesis. Methods: RNA sequencing was applied to hearts from mice after 8 weeks of voluntary exercise-induced physiological hypertrophy and cardiomyogenesis or transverse aortic constriction for 2 or 8 weeks to induce pathological hypertrophy or heart failure. The top lncRNA candidate was overexpressed in hearts with adeno-associated virus vectors and inhibited with antisense locked nucleic acid-GapmeRs to examine its function. Downstream effectors were identified through promoter analyses and binding assays. The functional roles of a novel downstream effector, dachsous cadherin-related 2 (DCHS2), were examined through transgenic overexpression in zebrafish and cardiac-specific deletion in Cas9-knockin mice. Results: We identified exercise-regulated cardiac lncRNAs, called lncExACTs. lncExACT1 was evolutionarily conserved and decreased in exercised hearts but increased in human and experimental heart failure. Cardiac lncExACT1 overexpression caused pathological hypertrophy and heart failure; lncExACT1 inhibition induced physiological hypertrophy and cardiomyogenesis, protecting against cardiac fibrosis and dysfunction. lncExACT1 functioned by regulating microRNA-222, calcineurin signaling, and Hippo/Yap1 signaling through DCHS2. Cardiomyocyte DCHS2 overexpression in zebrafish induced pathological hypertrophy and impaired cardiac regeneration, promoting scarring after injury. In contrast, murine DCHS2 deletion induced physiological hypertrophy and promoted cardiomyogenesis. Conclusions: These studies identify lncExACT1-DCHS2 as a novel pathway regulating cardiac hypertrophy and cardiomyogenesis. lncExACT1-DCHS2 acts as a master switch toggling the heart between physiological and pathological growth to determine functional outcomes, providing a potentially tractable therapeutic target for harnessing the beneficial effects of exercise.

The splicing factor hnRNPL demonstrates conserved myocardial regulation across species and is altered in heart failure

Identification of alternative splicing regulatory patterns and characteristic splicing factors in heart failure using RNA-seq data and machine learning

RNA Helicase DDX5 Maintains Cardiac Function by Regulating CamkIIδ Alternative Splicing

Transcriptome Analysis Reveals Distinct Patterns of Long Noncoding RNAs in Heart and Plasma of Mice with Heart Failure.

Relationship between HSPA1A-regulated gene expression and alternative splicing in mouse cardiomyocytes and cardiac hypertrophy

CRISPLD1: a novel conserved target in the transition to human heart failure

Abstract We130: Novel Role of RBFox1 in Myocardial Infarction Induced Heart Failure

Ischemic heart injury leads to HIF1-dependent differential splicing of CaMK2γ

Direct interaction between hnRNP‐M and CDC5L/PLRG1 proteins affects alternative splice site choice

Therapeutic potential of alternative splicing in cardiovascular diseases

KHSRP ameliorates acute liver failure by regulating pre-mRNA splicing through its interaction with SF3B1

Altered Long Noncoding Rna Expression Profiles In The Myocardium Of Rats With Ischemic Heart Failure

Nanopore long-read RNA sequencing reveals functional alternative splicing variants in human vascular smooth muscle cells

Exploring the Crosstalk Between LMNA and Splicing Machinery Gene Mutations in Dilated Cardiomyopathy

lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth

Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy

Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19

Heart failure with preserved ejection fraction in pigs causes shifts in post-transcriptional checkpoints

Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans

HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis

LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy